Home » Newsletters » BioWorld Science

BioWorld Science

May 14, 2014

View Archived Issues

BACE1 inhibitor tested for retinal beta-amyloidosis

Safety and efficacy of anti-CHST15 dsRNA in patients with Crohn's disease

GeneSight pharmacogenomic test improves odds of response to antidepressants

Mitsubishi Tanabe Pharma reflects on accomplishments of fiscal 2013

BTZ-169 demonstrates significant efficacy for N. brasiliensis infection

Researchers present promising in vitro data for VCP-746

Dainippon Sumitomo Pharma offers overview of fiscal 2013

Excellagen selected for use with stem cells in E.U.-funded human study

Shin Poong's neuroprotective compound shows promising preclinical results

Jubilant Biosys and Orion form collaborative pain management program

Kythera Biopharmaceuticals submits ATX-101 NDA for submental fat reduction

MabVax Therapeutics and Telik agree to merge

Origenis researchers patent new protein kinase inhibitors

Roche discloses novel Abeta production inhibitors

Berg and Medical University of South Carolina form collaboration to discover lupus biomarkers

Janssen presents novel antivirals for RSV infection

Abbott reports results for investigational infection diagnostic

New agents for HCV infection disclosed by Merck & Co.

Aslan Pharmaceuticals and CSL to develop new therapy for asthma

Janssen submits sNDAs to FDA for Invega Sustenna

FDA clears transfer of orphan drug designation for intrathecal resiniferatoxin to Sorrento

Inovio acquires rights to preclinical therapies for Alzheimer's and MS

Lysosomal Therapeutics receives funding for neurodegenerative disease research

Xenetic Biosciences reports phase I results for oxyntomodulin analogue

Incyte and MedImmune to collaborate on cancer immunotherapy combination trial

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...